The stock market had a wild ride recently, with some companies seeing huge gains while others took a big hit. Let's break it down.

Zenas BioPharma, a biotech company, saw its stock drop by more than half after their new drug showed promise in trials. The drug, obexelimab, is meant to treat a rare disease called IgG4-RD. Even though the drug met its main goals in the trial, investors weren't impressed. The company also said they might not get some money they were expecting from a previous deal. Despite this big drop, the company's stock is still up a lot over the past year.

On the other hand, Novo Nordisk, a Danish drug company, saw its stock rise after they introduced a new weight-loss pill in the US. The pill, called Wegovy, is already making waves in the market. The company says it could help the more than 100 million Americans living with obesity. The pill isn't cheap, with the highest dose costing nearly $300 a month.

In other news, the housing market is still struggling. Home sales are near historic lows, and mortgage rates are still high. But there's some hope for the future. Experts think mortgage rates will stay around 6% in 2026, which could be a good time for people to buy a home.

Big banks are also in the spotlight. They pay very little interest on savings accounts, which means people aren't earning much on their money. But there are other options out there. Some online banks offer much higher interest rates, which could mean more money in your pocket.

And if you're a recent graduate, you might be wondering what to do next. Some jobs are in high demand, like mental health counselors and lawyers. But others are being replaced by AI. It's important to think about what skills you have and what jobs will be around in the future.

Market Moves: Big Wins and Losses in the World of Stocks

Actions